Code · STATUTE-COMPILATIONS · Food and Drug Administration Safety and Innovation Act · Sec. 510

Sec. 510. PEDIATRIC RARE DISEASES

91 words·~1 min read·/statute-compilations/comps-9932/sec-510

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

## SEC. 510 PEDIATRIC RARE DISEASES ###

(a)Public Meeting Not later than 18 months after the date of enactment of this Act, the Secretary shall hold at least one public meeting to discuss ways to encourage and accelerate the development of new therapies for pediatric rare diseases. ###

(b)Report Not later than 180 days after the date of the public meeting under subsection (a), the Secretary shall issue a report that includes a strategic plan for encouraging and accelerating the development of new therapies for treating pediatric rare diseases.